期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

脑胶质瘤中CLDN-7基因甲基化状态及蛋白表达的研究 被引量：3

Methylation of CLDN-7 gene and protein expression in glioma
下载PDF
导出
摘要 目的探讨脑胶质瘤血浆中CLDN-7基因的甲基化状况及蛋白表达的关系。方法采用巢式PCR、亚硫酸氢盐测序PCR(BSP)及免疫组织化学技术方法,检测56例脑胶质瘤血清标本中CLDN-7基因启动子区CpG岛的甲基化状态,分析其甲基化程度、蛋白表达和临床资料之间的相关性。结果脑胶质瘤患者血清中CLDN-7基因启动子区甲基化率为35.3%(18/51),按WHO病理分级,其中低级别(Ⅰ～Ⅱ级)组胶质瘤中基因启动子区甲基化率25.0%(9/36)低于高级别(Ⅲ～IV级)组甲基化率60.0%(9/15),两者之间存在显著差别(P<0.05);甲基化蛋白表达阳性率为55.6%(10/18),未甲基化的蛋白阳性表达率为84.8%(28/33)。结论 CLDN-7基因启动子区CpG岛中存在甲基化现象,与脑胶质瘤发生有关;基因的甲基化率与蛋白表达呈负相关关系。 Objective To study the methylation of CLDN-7and protein expression in glioma.Methods nPCR and BSP was adopted to investigate the promoter frequency of these genes in 56 cases of glioma tissue.The CLDN-7 expression in 56 glioma specimens was examined by immunohistochemistry method.The relationship between frequency of methylation of this gene and clinical disease material was analyzed.Results In patientions with glioma,the frequency of methylation in CLDN-7 was 35.3%（18/51）.The rate of CLDN-7 promoter methylation in grades Ⅰ~Ⅱ gliomas was significantly lower than that（60.0%）in grades Ⅲ~Ⅳ gliomas（P0.05）.Conclusion CLDN-7 promoter（CpG island）hypermethylation exists in glioma,which may correlate with the occurrence of glioma.
作者 刘正 徐培坤 朱立新 成金民
机构地区 安徽医科大学第一附属医院神经外科
出处 《安徽医药》 CAS 2013年第1期53-55,共3页 Anhui Medical and Pharmaceutical Journal
基金 安徽省卫生厅基金(No 2113B013)
关键词 紧密连接蛋白-7 CPG岛 甲基化 脑胶质瘤 CLDN-7 CpG methylation glioma
分类号 R739.4 [医药卫生—肿瘤]
  • 相关文献

参考文献9

  • 1Tsukita S,Furuse M,Itoh M.Multifunctional strands in tight junctions[J].Nat Rev Mol Cell Biol,2001,2(4):285-293.
  • 2Dahiya N,Becker KG,Wood WH,et al.Claudin-7 is frequently overexpressed in ovarian cancer and promotes invasion[J].PLoS One,2011,6(7):22119.
  • 3Kominsky SL,Argani P,Korz D,et al.Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast[J].Oncogene,2003,22(13):2021-2033.
  • 4Morin PJ.Claudin proteins in human cancer:promising new targets for diagnosis and therapy[J].Cancer Res,2005,65(21):9603-9606.
  • 5Lioni M,Brafford P,Andl C,et al.Dysregulation of claudin-7 leads to loss of E-Cadherin expression and the increased invasion of esophageal squamous cell carcinoma cells[J].Am J Pathol,2007,170(2):709-721.
  • 6Kurkjian C,Kummar S,Murgo AJ.DNA methylation:its role in cancer development and therapy[J].Curt Probl Cancer,2008,32(5):187-235.
  • 7谢坤,朱立新,耿小平,李晓明,熊奇如,孙昀,刘念.肝细胞癌中CHFR、EDNRB和3-OST-2基因异常甲基化的研究[J].中华消化外科杂志,2007,6(2):117-120. 被引量：5
  • 8钱波,朱立新,耿小平,熊奇如,钱叶本,李晓明.肝细胞癌MGMT、DAPK、THBS1和RIZ1基因甲基化研究[J].中华普通外科杂志,2005,20(5):291-294. 被引量：12
  • 9赵中海,耿小平,朱立新,李晓明,刘宗石.肝细胞癌组织中RAS相关区域家族蛋白1A、肿瘤高甲基化基因1和P73基因的异常甲基化[J].中华外科杂志,2005,43(23):1528-1532. 被引量：6

二级参考文献25

  • 1Zhong S, Tang MW, Yeo W, et al. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinoma. Clin Cancer Res, 2002, 8: 1087-1092.
  • 2Liew CT, Li HM, Lo KW, et al. High frequency of p16INK4A gene alterations in hepatocellular carcinoma. Oncogene, 1999, 18: 789-795.
  • 3Ivy HN, Wong YM, Dennis L, et al. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res, 1999, 59: 71-73.
  • 4Dammann R, Li C, Yoon JH, et al. Epigenetic inactivation of a RAS association of domain family protein from the lung tumor suppressor locus ep21.3. Nat Genet, 2000, 25: 315-319.
  • 5Ortiz-Vega S, Khokhlatchev A, Nedwidek M, et al. The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Norel. Oncogene, 2002, 12: 1381-1390.
  • 6Agathanggelou A,Honorio S, Macartney DP, et al. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian rumors. Oncogene, 2001, 20: 1509-1518.
  • 7Schagdarsurengin U, Wilkens L, Steinemann D, et al. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma. Oncogene, 2003, 22: 1866-1871.
  • 8Zhong S, Yeo W, Tang MW, et al. Intensive hypermethylation of the CpG island of Ras Association Domain Family 1A in hepatitis B virus-associated hepatocellular carcinomas. Clin Cancer Res, 2003, 9: 3376-3382.
  • 9Lee S, Lee HJ, Kim JH, et al. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Am J Pathol, 2003, 163:1361-1378.
  • 10Wales MM, Biel MA, Deiry W, el al. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat Med, 1995, 1: 570-577.

共引文献19

同被引文献33

  • 1Wakabayashi T, Natsume A, Hatano H, et al. P16 promoter methylation in the serum as abasis for the molecular diagnosis of gliomas [ J ]. Eurosurgery, 2009,64 ( 3 ) :455 - 61.
  • 2Hyndman K A, Miyamoto M M, Evans D H. Phylogeny, taxono- my, and evolution of the endothelin receptor gene family[ J]. Mol Phylogenet Evol, 2009, 52 (8) :677 - 87.
  • 3Kurkjian C, Kammar S, Murgo A J. DNA methylation: its role in cancer development and therapy [ J ]. Curt Probl Cancer, 2008, 32 (5): 187-235.
  • 4Zhao B J, Sun D G, Zhang M, et al. Identification of aberrant promoter methylation of EDNRB gene in esophageal squamous cell carcinoma [J]. Dis Esophagus, 2009,22 (11): 55-61.
  • 5Feinberg A P, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer[ J]. Nat Rev Genet, 2006, 7 (1) : 21 - 33.
  • 6Qureshi S A, Bashir M U, Yaqinudding A. Utility of DNA methy- lation markers for diagnosing cancer[ J]. Int J Surg, 2010, 8 (3) : 194 -8.
  • 7Chen S C, Lin C ~, Chen Y H, et al. Aberrant promoter methyla- tion of EDNRB in lung cancer in Taiwan [ J ]. Oncol Reap, 2006, 15(1): 167-72.
  • 8Bastian P J, Ellinger J, Heukamp L C, et al. Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB and other gene loci in patients undergoing radical prostatectomy [ J ]. Eur Urol, 2007, 51 (7) : 665 - 74.
  • 9Yates D R, Rehman I, Abbod M F, et al. Promoter hyper methyl- ation identifies progression risk in bladder cancer [ J]. Clin Canc- er Res, 2007, 13 (7) : 2046 -53.
  • 10Brooks A S, Oostra B A, Hofstra R M. Studying the genetics of Hischsprung, s disease: unraveling an oligogenic disorder [ J ]. Clin Genet, 2005, 67 ( 1 ) : 6 - 14.

引证文献3

二级引证文献9

安徽医药
2013年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部